(Q80764358)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17685394%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

title

Immunotherapy of murine colon cancer using receptor tyrosine kinase EphA2-derived peptide-pulsed dendritic cell vaccines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17685394%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

1 reference

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17685394%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

author name string

Shinjiro Yamaguchi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17685394%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Tomohide Tatsumi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17685394%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Tetsuo Takehara

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17685394%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Ryotaro Sakamori

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17685394%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Akio Uemura

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17685394%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Tsunekazu Mizushima

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17685394%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Kazuyoshi Ohkawa

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17685394%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Norio Hayashi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17685394%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

publication date

1 October 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17685394%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17685394%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

volume

110

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17685394%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

page(s)

1469-1477

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17685394%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17685394%20AND%20SRC:MED&resulttype=core&format=json

Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo

3 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22958

7 January 2021

Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22958

7 January 2021

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22958

7 January 2021

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22958

7 January 2021

DNA-based immunization by in vivo transfection of dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22958

7 January 2021

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22958

7 January 2021

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22958

7 January 2021

Dendritic cell-based immunotherapy of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22958

7 January 2021

Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22958

7 January 2021

Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22958

7 January 2021

Multiple roles of EPH receptors and ephrins in neural development

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22958

7 January 2021

Control of cell behaviour by signalling through Eph receptors and ephrins.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22958

7 January 2021

Genomic structure and loss of heterozygosity of EPHB2 in colorectal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22958

7 January 2021

Eph receptors and ephrin ligands: embryogenesis to tumorigenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22958

7 January 2021

Molecular classification of cutaneous malignant melanoma by gene expression profiling

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22958

7 January 2021

Antiangiogenic and antitumor efficacy of EphA2 receptor antagonist

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22958

7 January 2021

The ephrins and Eph receptors in angiogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22958

7 January 2021

Vaccination with EphA2-derived T cell-epitopes promotes immunity against both EphA2-expressing and EphA2-negative tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22958

7 January 2021

Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22958

7 January 2021

CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22958

7 January 2021

Defective CD8 T Cell Memory Following Acute Infection Without CD4 T Cell Help

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22958

7 January 2021

Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22958

7 January 2021

Unpulsed dendritic cells induce broadly applicable anti-tumor immunity in mice.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22958

7 January 2021

Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22958

7 January 2021

Vaccination of hormone-refractory prostate cancer patients with peptide cocktail-loaded dendritic cells: results of a phase I clinical trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22958

7 January 2021

Clinical response in Japanese metastatic melanoma patients treated with peptide cocktail-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22958

7 January 2021

Identifiers

DOI

10.1002/CNCR.22958

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17685394%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference